Thrombolysis in the 3-to 4.5-Hour Window What Do ECASSkeptics Want?

被引：4
作者：
Selim, Magdy H. [1 ]
Molina, Carlos A. [2 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Stroke Div, Boston, MA 02215 USA
[2] Hosp Vall dHebron Barcelona, Dept Neurol, Stroke Unit, Barcelona 08035, Spain
来源：
STROKE | 2014年 / 45卷 / 03期
关键词：
stroke; tissue plasminogen activator; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; INTRAVENOUS THROMBOLYSIS; ALTEPLASE; ONSET;
D O I：
10.1161/STROKEAHA.113.004265
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：916 / 917
页数：2
相关论文
共 6 条
  • [1] Results of Intravenous Thrombolysis Within 4.5 to 6 Hours and Updated Results Within 3 to 4.5 Hours of Onset of Acute Ischemic Stroke Recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR) An Observational Study
    Ahmed, Niaz
    Kellert, Lars
    Lees, Kennedy R.
    Mikulik, Robert
    Tatlisumak, Turgut
    Toni, Danilo
    [J]. JAMA NEUROLOGY, 2013, 70 (07) : 837 - 844
  • [2] Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR
    Ahmed, Niaz
    Wahlgren, Nils
    Grond, Martin
    Hennerici, Michael
    Lees, Kennedy R.
    Mikulik, Robert
    Parsons, Mark
    Roine, Risto O.
    Toni, Danilo
    Ringleb, Peter
    [J]. LANCET NEUROLOGY, 2010, 9 (09) : 866 - 874
  • [3] Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke A Metaanalysis
    Lansberg, Maarten G.
    Bluhmki, Erich
    Thijs, Vincent N.
    [J]. STROKE, 2009, 40 (07) : 2438 - 2441
  • [4] Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
    Lees, Kennedy R.
    Bluhmki, Erich
    von Kummer, Ruediger
    Brott, Thomas G.
    Toni, Danilo
    Grotta, James C.
    Albers, Gregory W.
    Kaste, Markku
    Marler, John R.
    Hamilton, Scott A.
    Tilley, Barbara C.
    Davis, Stephen M.
    Donnan, Geoffrey A.
    Hacke, Werner
    Ninds, Ecass Atlantis
    [J]. LANCET, 2010, 375 (9727) : 1695 - 1703
  • [5] The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
    Sandercock, Peter
    Wardlaw, Joanna M.
    Lindley, Richard I.
    Dennis, Martin
    Cohen, Geoff
    Murray, Gordon
    Innes, Karen
    Venables, Graham
    Czlonkowska, Anna
    Kobayashi, Adam
    Ricci, Stefano
    Murray, Veronica
    Berge, Eivind
    Slot, Karsten Bruins
    Hankey, Graeme J.
    Correia, Manuel
    Peeters, Andre
    Matz, Karl
    Lyrer, Phillippe
    Gubitz, Gord
    Phillips, Stephen J.
    Arauz, Antonio
    Baigent, Colin
    Chadwick, David
    Tyrrell, Pippa
    Lowe, Gordon
    Farrall, Andrew
    von Kummer, Rudiger
    Cala, Lesley
    von Heijne, Anders
    Morris, Zoe
    Adami, Alessandro
    Potter, Gillian
    Brady, Nick
    Collins, Rory
    Bath, Philip
    van Gijn, Jan
    Gray, Richard
    Hart, Robert
    Yusuf, Salim
    Muir, Keith
    Brainin, Michael
    Engelter, Stefan
    Terent, Andreas
    Norrving, Bo
    Wester, Per
    Clark, Alison
    Perry, David
    Soosay, Vera
    Buchanan, David
    [J]. LANCET, 2012, 379 (9834) : 2352 - 2363
  • [6] Thrombolysis at 3-4.5 Hours after Acute Ischemic Stroke Onset - Evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) Registry
    Shobha, Nandavar
    Buchan, Alastair M.
    Hill, Michael D.
    [J]. CEREBROVASCULAR DISEASES, 2011, 31 (03) : 223 - 228
1